Worcester, MA, United States of America

John V Gazzaniga

This inventor holds 1 USPTO granted patent. Top assignee: Pliva D.d.. Active years: 2008.


Average Co-Inventor Count = 13.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: John V Gazzaniga: Innovator in Antibacterial Compounds

Introduction

John V Gazzaniga is a notable inventor based in Worcester, MA (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of antibacterial compounds. His innovative work focuses on the inhibition of critical enzymes involved in bacterial cell-wall synthesis.

Latest Patents

Gazzaniga holds a patent for "Heterocyclic compounds and uses thereof as D-alanyl-D-alanine ligase inhibitors." This invention relates to D-Ala-D-Ala ligase inhibitors that possess antibacterial properties. The compounds are designed to bind and inhibit D-Ala-D-Ala ligase, which is essential for bacterial cell-wall synthesis. This patent highlights his expertise in creating compounds that can potentially combat bacterial infections.

Career Highlights

Gazzaniga's career is marked by his work at Pliva D.d., where he has contributed to various research initiatives. His focus on developing effective antibacterial agents has positioned him as a key figure in the pharmaceutical industry. With a patent portfolio that includes innovative compounds, he continues to advance the field of medicinal chemistry.

Collaborations

Throughout his career, Gazzaniga has collaborated with esteemed colleagues such as Paul J Ala and Janid A Ali. These partnerships have fostered a collaborative environment that enhances research and development efforts in the field of antibacterial agents.

Conclusion

John V Gazzaniga is a prominent inventor whose work in antibacterial compounds has the potential to make a significant impact on public health. His innovative approach to inhibiting critical enzymes in bacteria showcases the importance of research in combating antibiotic resistance.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…